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The immense variety of neuronal phenotypes in the 
vertebrate nervous system is apparent in considering 
just the process of chemical transmission. There are 
approximately 12 known classical neurotransmitters 
and more than 30 neuropeptides thus far identified, and 
individual neurons simultaneously synthesize, store, 
and secrete one or more classical transmitters in addi- 
tion to three or more neuropeptides. The transmitters 
and peptides are expressed in an exceedingly large 
number of different combinations in different parts of 
the nervous ystem. Although there are useful general- 
izations as to the frequency of certain transmitter- 
peptide combinations, there are innumerable xcep- 
tions to these rules. How the particular combinations 
produced in each neuron are specified uring develop- 
ment is a challenging question. The magnitude of this 
problem becomes clear if one calculates the number of 
possible combinations if a neuron is to produce 2 trans- 
mitters out of a possible 12 and 3 peptides out of a 
possible 30. There are 267,960 different potential 
phenotypes in this example. 
It has become increasingly clear that such phenotypic 
decisions are not made solely on the basis of a cell's 
lineage history. Clonal analysis in both the central and 
peripheral vertebrate nervous ystems in situ has dem- 
onstrated that multipotential precursor cells can, right 
up to their final division, give rise to a variety of 
neurons and, in some cases, gila (Turner and Cepko 
1987; Holt et al. 1988; Price and Thurlow 1988; Wetts 
and Fraser 1988; Bronner-Fraser and Fraser 1989; 
Galileo et al. 1990). This suggests hat the precursor 
cells (and their immediate daughter c lls) are not com- 
mitted to a single fate (see also Tomlinson 1988; An- 
derson 1989). That postmitotic neurons can be in- 
fluenced in their phenotypic hoices by environmental 
signals has been convincingly shown for cells of both 
peripheral and central origin in vitro (see, e.g., Patter- 
son 1978; Kessler et al. 1984; Iacovitti et al. 1989; Adler 
and Hatlee 1989; Schoenen et al. 1989). Moreover, a 
variety of manipulations of cell position in vivo have 
indicated that the identity of a neuron's target can 
influence transmitter and peptide choices (McMahon 
and Gibson 1987; Schotzinger and Landis 1988; Wall 
and Taghert 1989). Many of these choices are revers- 
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ible, and changes in transmitter and peptide phenotype 
can be part of normal development in situ, as growing 
neurons encounter new environments, in both ver- 
tebrate and invertebrate systems (Hayashi et al. 1983; 
Landis and Keefe 1983; Gesser and Larsson 1985; Hap- 
pola et al. 1986; Koizumi and Bode 1986; Tublitz and 
Sylwester 1990). 
What are the intercellular signals that control these 
phenotypic decisions? Using primary neuronal cultures 
as assay systems, it has been possible to identify a 
number of these signals and to characterize their 
biological activities and their biochemical properties 
(Fukada 1985; Wong and Kessler 1987; Adler et al. 
1989; Lin et al. 1989; McManaman et al. 1989; Saadat 
et al. 1989; Stockli et al. 1989; Yamamori et al. 1989; 
Rao et al. 1990a). An early generalization that is arising 
from this work is that although these neuronal differen- 
tiation factors have distinct effects on a target neuron 
population, their effects can be partially overlapping or 
redundant. For instance, several f ctors with discrete 
biochemical properties can induce acetylcholine (ACh) 
production in cultured striatal and sympathetic neu- 
rons, but their effects on the expression of other trans- 
mitters and neuropeptides are distinct (Kessler 1986; 
Nawa and Patterson 1990). This emerging picture has a 
striking parallel in the control of phenotypic decisions 
in the hematopoietic system. Here too, biochemically 
diverse proteins produce distinct differentiation re- 
sponses, but their effects can be partially overlapping 
(Metcalf 1989). Thus, although four hematopoietic reg- 
ulators, with no sequence identity, elicit different ar- 
rays of derivatives from multipotential stem cell pre- 
cursors, all four promote granulocyte and/or mac- 
rophage differentiation. In fact, this analogy between 
the nervous and hematopoietic systems has recently 
been carried a step further with the demonstration that 
the same protein can influence differentiation i both 
systems (Yamamori et al. 1989). 
In this paper, we further examine the effects of this 
recombinant protein, known as leukemia inhibitory 
factor (LIF) and cholinergic differentiation factor 
(CDF), on cultured neurons. We present the dose- 
dependence of its effects on the expression of various 
transmitters and neuropeptides in sympathetic neu- 
rons, and we show that it can act on another type of 
neuron eticiting somewhat different effects. The de- 
velopmental profile of the onset of neuropeptide induc- 
tion is also presented, and the reversibility of these 
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effects is described. The conclusions are that CDF/L IF  
can act on several different types of neurons, that the 
response in each neuron is probably influenced by its 
lineage history, and that the factor must be continually 
present to maintain its effects on neuropeptide gene 
expression. 
METHODS 
Cell cultures. Sympathetic neuron cultures were 
prepared from neonatal rat superior cervical ganglia 
(SCG) using enzymatic dissociation and growth in L15- 
CO 2 medium plus 5% rat serum and nerve growth 
factor (NGF),  according to the methods of Hawrot and 
Patterson (1979). Sensory neuron cultures were also 
prepared from dorsal root ganglia (DRG)  of neonatal 
rats in the same way and grown in F-12 medium con- 
taining the N2 medium nutrient supplement and NGF 
(Lindsay 1988), Serum-free, heart-cell-conditioned 
medium (CM) was prepared according to the method 
of Fukada (1980). 
Transmitter and neuropeptide assays, After 14-16 
days in culture, the intact sympathetic and sensory 
neurons were assayed for ACh and catecholamine 
(CA) synthesis from radioactive precursors, according 
to the methods of Mains and Patterson (1973). Sister 
neuronal cultures containing 1-6000 neurons were also 
extracted, and their neuropeptide contents were as- 
sayed by radioimmunoassay, according to the methods 
of Nawa and Sah (199l)). The authenticity of these 
peptides was previously determined by high-perform- 
ance liquid chromatography (Nawa and Sah 1990). The 
data are xpressed as fmoles transmitter or peptide per 
1000 neurons assayed. 
Materials. Recombinant mouse and human CDF I  
LIF produced by Escherichia coli (Gearing et al. 1989) 
was the kind gift from Dr. D. Metcalf and associates at 
the Walter and Eliza Hall Institute in Melbourne. NGF 
was produced by J. Carnahan. All other materials were 
produced according to the methods of Hawrot and 
Patterson (1979) and Nawa and Patterson (1990). 
RESULTS 
Induction of Neuropeptides 
by Recombinant CDF/LIF 
It was shown previously that heart cell CM can in- 
duce the synthesis of several neuropeptides and their 
mRNAs,  as well as ACh in cultured sympathetic neu- 
rons (Nawa and Sah 1990). Moreover,  these neurons 
can respond to recombinant CDF/L IF  by the induction 
of ACh synthesis and the reduction of CA synthesis 
(Yamamori et al. 1989). Therefore, we sought to de- 
termine whether the peptide inductions by CM were 
also due to CDF/L IF  (see also Nawa and Patterson 
1990). Using recombinant CDF/L IF ,  we find that this 
protein does increase neuronal substance P (SP) and 
somatostatin (SOM),  whereas it reduces neuropeptide 
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Figure 1. Dose dependence of recombinant CDF/LIF effects 
on neurotransmitter and neuropeptide choice. Recombinant 
mouse CDF/LIF was added at various concentrations (abcis- 
sa) to cultured sympathetic neurons for 12 days. Transmitter 
synthesis and peptide content were measured as described in 
Methods. The values are normalized to neuron number by 
counting neurons, and the data are calculated as the mean +- 
S.E.M. The ratio to the control (no CDF/LIF) value is shown 
on the ordinate. The control values were SP = 0.07 m 0,03, 
SOM = 34.0 +- 2.0, and NPY = 1100.0 +- 200.0 fmoles/1000 
neurons, and ACh = 170.0 -+ 2.0, and CA = 3600.0 _+ 500.0 
fmoles/1000 neurons/hour. The cultures contained the follow- 
ing numbers of neurons: control-8448 +- 1260, 17 pM= 
6971 -+ 774, 50 pM = 6507 + 788, 170 pM : 5016 _+ 1027, 500 
pM = 2760 +- 270, 1.7 nM= 1582 -+ 224, 5 nM= 1020 -+ 39. The 
lower number of surviving neurons at the higher CDF/LIF 
concentrations is not yet explained. Since such an effect was 
not observed for purified CDF (Fukada 1985; Nawa and Pat- 
terson 1990), it is possible that the recombinant preparation 
contains a toxic contaminant. It is clear, however, that dif- 
ferential survival of various populations of predetermined 
neurons is not the explanation for the effects on transmitter/ 
peptide phenotype (Patterson 1978; Potter et al. 1986; Nawa 
and Sah 1990). 
Y (NPY) (Fig. 1). The inductions of ACh,  SP, and 
SOM were observed at CDF/L IF  concentrations well 
below 0.1 riM, with approximately 2 nM required for 
maximal induction of SP and ACh. The reductions in 
CA and NPY were less marked but required protein 
concentrations similar to those for the positive induc- 
tions. These effects are all consistent with previous 
results obtained using the protein purified from CM. 
The NPY suppression was not obvious when crude 
heart cell CM was added to the neurons (Nawa and Sah 
1990; see also Marek and Mains 1989). The lack of 
effect with CM could be due to a lower concentration of
CDF/L IF  in the medium than was added with the 
recombinant protein or to the presence of a factor in 
the medium that acted to counter the effect of CDF/  
LIF. 
Time Course of Peptide Induction 
and Its Reversibility 
The induction of ACh synthesis in cultured sym- 
pathetic neurons by heart cell CM is slow, requiring 
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several weeks for the major increase to occur (Patter- 
son and Chun 1977; see also Johnson et al. 1976). 
Given that the same protein can induce the production 
of several neuropeptides, it was of interest to determine 
whether the peptide changes followed a time course 
similar to that of ACh. When sympathetic neurons are 
grown in a 100% volume equivalent of heart cell CM, 
the developmental profiles of SP and SOM induction 
(Fig. 2) are both very similar to that observed previous- 
ly for ACh. The major induction of vasoactive intesti- 
nal polypeptide (VIP), however, is considerably 
slower, with the major increase occurring after 12 days 
and still rising at 24 days. Thus, there appear to be two 
phases in the VIP induction, the second of which does 
not correspond in time to those of ACh, SP, and SOM. 
These changes in phenotype in postmitotic neurons 
raise the question of reversibility and age dependence. 
The culture paradigm offers an excellent opportunity to
ask whether the neuropeptide changes induced by CM 
are reversible. When CM was withdrawn from the 
sympathetic neurons on day 12, a dramatic decline in 
SP, SOM, and VIP levels was observed (Fig. 2). The 
apparent rise in VIP seen at day 24 in the absence of 
CM is unexplained at present. Overall then, not only 
the induction of these peptides, but their maintenance 
appears to be completely dependent on the continued 
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Figure 2. Time course of neuropeptide induction and its re- 
versibility. Sympathetic neurons were grown in 100% volume 
equivalent of heart cell CM from day 2. On days 5, 8, 12, and 
24, total peptides were extracted from three sister cultures, 
and radioimmunoassays were carried out for SP, SOM, and 
VIP (solid lines). On day 12, CM was withdrawn from some of 
the CM cultures to assess the reversibility of its effects (dashed 
lines). The culture medium was changed every 2 days, and 10 
/zm cytosine arabinoside wasadded on days 0, 2, 5, 10, and 16 
to suppress nonneurona[ cell proliferation. Neuronal numbers 
did not differ significantly among the various groups of cul- 
tures. 
Neuronal Specificity of CDF/LIF 
The dramatic hanges in gene expression elicited in 
sympathetic neurons by CDF/LIF raises the question 
as to whether this factor is specific for these neurons or 
whether it can act in a widespread fashion in the ner- 
vous system. If it can act on other neurons, does it 
induce the same set of transmitters and peptides that it 
does in sympathetic neurons? Since a similar choliner- 
gic factor from skeletal muscle can induce ACh synthe- 
sis in cultured sensory neurons from nodose ganglia 
(Mathieu et al. 1984), we tested recombinant CDF/ 
LIF on sensory neurons, in this case from DRG. The 
results of such an experiment are given in Table 1. The 
most significant changes induced by CDF/LIF in the 
DRG neurons are 13-fold increases in ACh synthesis 
and VIP content. There is also a small reduction in SP. 
Therefore, CDF/LIF does alter the phenotype of sen- 
sory neurons, and it induces several of the same 
changes that it does in sympathetic neurons, namely, 
ACh and VIP induction. The effects on the DRG 
neurons are, however, not identical to those with sym- 
pathetic neurons, since SP and SOM are not increased 
in the sensory neurons. A reduction in CA synthesis i
also not apparent, but the control evels of CA synthe- 
sis are too low to be sure if a CA suppression effect 
could be seen. Similarly, the large errors in the NPY 
measurements mitigated against drawing firm conclu- 
sions about a lowering of the Ievel of this peptide. 
These results support he idea that a neuron's lineage 




There are several parallels in the generation of cell 
diversity in the neural crest lineage and in the hemato- 
poietic system: Both systems appear to arise from mul- 
tipotent stem cells that give rise to progenitor cells 
committed to particular sublineages, andin both sys- 
tems, extracellular signals can influence which differen- 
tiation pathways are taken (Anderson 1989). It is the 
last point concerning phenotypic instructive factors to 
which the present work relates. It was previously shown 
that the CDF from heart cells can alter neuropeptide as
well as neurotransmitter expression in cultured sym- 
pathetic neurons (Nawa and Patterson 1990), and we 
here demonstrate that recombinant CDF/LIF dupli- 
cates these various activities (see also Yamamori et al. 
1989). That this protein also influences the prolifer- 
ation and differentiation f a myeloid cell line (Gearing 
et al. 1987) draws the two systems together at the 
molecular level as well. It should be noted, however, 
that it is not yet known how or when LIF acts in the 
hematopoietic l neage (Metcalf and Gearing 1989). Re- 
cent evidence implicates CDF/LIF  in the control of cell 
proliferation and differentiation i many different is- 
sues, from the earliest embryo through adulthood 
(Gough and Williams 1989). These findings suggest 
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Table 1. Effect of CDF/LIF on Neurotransmitter and Neuropeptide Choices in Sympathetic 
and Sensory Neurons 
Neuron CDF/LIF ACh CA SP SOM VIP NPY 
SCG + 4400 -+ 400 730 -+ 180 59 -+ 6.0 48 -+ 5 9.7 +- 0.6 
- 330+50 3200"+300 0.4-+0.0 4-+2 1.1 -+0.4 
DRG + 53-+5 0.4-+0.2 2.1-+0.2 2.5+1.3 2.7-+0.4 66-+28 
- 4 + 4 0.6 -+ 0.4 5.0 -+ 0.9 3.5 -+ 1.6 0.2 -+ 0.2 75 -+ 21 
Sympathetic neurons from the SCG were cultured in serum-containing medium with or without 1 nM 
recombinant human CDF/LIF for t2 days. Sensory neurons from the DRG were grown in defined medium 
as described in Methods. To suppress nonneuronal cell growth, 10 gM cytosine arabinoside was added during 
the first 7 days (SCG) or between 24 a d 48 hours (DRG). The number of neurons did not differ significantly 
between the various groups of cultures, and nonneuronal cells were not observed in the SCG cultures. Some 
nonneuronal cells were observed in the DRG cultures, numbering <10% of the total cell population. 
Transmitters and peptides wereassayed as described in Methods. ACh and CA values are expressed as
fmoles/1000 neurons/hour, and the peptides are expressed asfmoles/1000 neurons. 
that it may be rewarding to study the effects of other 
cytokines and hematopoietic regulators on neuronal 
phenotypic hoices, as well as to investigate whether 
neuronal factors can influence hematopoietic decisions. 
Role of  CDF/L IF  In Situ 
To understand the role of CDF/L IF  in neuronal 
development in the intact organism, it will be necessary 
to localize the factor in situ, describe which cells have 
receptors for it, and to perform appropriate perturba- 
tion experiments. Although such data are not yet avail- 
able, one can ask if the effects of CDF/L IF  on cultured 
neurons mimic any of the phenotypes known from 
descriptive studies of normal neurons. The present ex- 
periments and those of Nawa and Patterson (1990) 
show that CDF/L IF  can each induce the expression of 
ACh and VIP while causing a corresponding reduction 
in CA and NPY. The striking aspect of these results is 
that these are precisely the pairs of transmitters and 
peptides that are generally colocalized together in 
cholinergic (ACh + VIP) and noradrenergic (CA+ 
NPY) peripheral neurons; these pairings have been 
termed one of the organizational principles of the sym- 
pathetic nervous ystem (Lundberg et al. 1982). Thus, 
we would expect that the natural neuronal differentia- 
tion signal operating in the sweat glands of the rat foot 
pad, for instance, where the noradrenergic-to-choliner- 
gic switch in phenotype is observed uring normal de- 
velopment (Landis and Keefe 1983), would regulate 
these pairs of transmitters and peptides coordinately, as 
does CDF/L IF .  The simplest picture would then invol- 
ve a unique neuronal differentiation signal for each 
distinct combination of transmitters and peptides. 
There are, however, a great many exceptions to the 
general rules of transmitter/peptide pairings. NPY is 
sometimes found in cholinergic neurons, for instance, 
and VIP in noncholinergic neurons (cf. Leblanc and 
Landis 1988). To take these exceptions into account, 
simple models might include separate differentiation 
factors for each transmitter and peptide or factors that 
both suppress and induce single or combinations of 
transmitters and peptides. Although it is clearly too 
early to draw firm conclusions, the data that are avail- 
able support both alternatives. That is, some purified 
neuronal differentiation factors, such as CDF/L IF ,  
ciliary neurotrophic factor, and membrane-associated 
neurotransmitter stimulating factor, can each induce 
the expression of several transmitters and peptides as 
well as suppress others (Wong and Kessler 1987; 
Ernsberger et al. 1989; Nawa and Patterson 1990; Rao 
et al. 1990a), whereas several newly described factors 
appear to have more narrow effects on neuronal gene 
expression (Nawa and Patterson 1990). 
In the particular case of the sympathetic nnervation 
of the sweat gland in the rat, a combination of factors 
may be required to explain the observed transmitter/ 
peptide phenotype. These axons switch from a CA 
phenotype to an ACh-VIP-CGRP (calcitonin-gene- 
related peptide) phenotype on arrival at this target 
(Landis et al. 1988; Schotzinger and Landis 1988). It is 
particularly noteworthy that SP has not been detected 
in these neurons because all three cholinergic factors 
known to act on cultured sympathetic neurons do in- 
duce SP (Wong and Kessler 1987; Nawa and Sah 1990; 
Rao et al. 1990b and unpubl.). Three hypotheses that 
can reconcile these results are s follows: (1) In none of 
these proteins is the factor acting normally in the sweat 
gland, (2) the sympathetic neurons do not show an SP 
response to CDF (for instance) in vivo, and (3) the SP 
part of the response to CDF (for example) is counter- 
balanced by another factor in the sweat gland that acts 
to suppress SP expression. In this regard, it is interest- 
ing that soluble extracts of rat foot pads (including 
sweat glands) contain a factor(s) that mimics the action 
of the known cholinergic factors on cultured sym- 
pathetic neurons, including the induction of SP (Rao et 
al. 1990b and unpubl.). 
Neuronal  Targets  for CDF/L IF  
Another aspect of the role of CDF/L IF  concerns 
how many types of neurons respond to it. That is, does 
the protein act only on the sympathetic neurons that 
were used as the assay for its purification, or can it act 
on other neurons that are normally cholinergic? Can it 
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induce cholinergic properties in neurons that do not 
normally display such a phenotype? The investigations 
of Weber et al. (1985) demonstrated that skeletal mus- 
cle CM contains a cholinergic neuronal differentiation 
factor that very closely resembles CDF/LIF.  The 
skeletal muscle protein can enhance cholinergic dif- 
ferentiation in cultures of partially purified rat motor 
neurons and nodose ganglion sensory neurons without 
altering neuronal survival (Mathieu et al. 1984; Mar- 
tinou et al. 1989). These findings suggest a potentially 
widespread role for this factor. We assayed recombi- 
nant CDF/L IF  on another population of neurons, 
DRG sensory neurons, that are not known to produce 
ACh normally in situ. CDF/L IF  does enhance ACh 
synthesis in these neurons, as well as VIP expression. 
Quantitatively, the observed increases are not as great 
as those seen with sympathetic neurons, but we have 
not yet attempted to optimize this effect by testing 
higher concentrations of factor or by testing DRG 
neurons from different developmental stages. 
What does the apparently widespread distribution of 
putative receptors for CDF/L IF  mean for its biological 
role? One possibility is that normally, in vivo, most 
neurons are not responsive to this factor. That is, the 
response observed here represents a derepression of 
the receptor in culture (or some other aspect of the 
response pathway); normally, expression of the CDF/ 
LIF receptor is closely regulated and restricted in de- 
velopmental time and location. It is also possible that 
many neurons do have the capacity to respond to this 
factor in situ but that expression of CDF/L IF  itself is 
closely regulated and restricted in developmental time 
and location. Yet another possibility is that many 
neurons do express the CDF/L IF  receptor and do en- 
counter the factor in situ, but they are prevented from 
responding to it by another factor in their environment. 
Such factors might include glial cells (Spiegel et al. 
1990) and neuronal activity (Walicke et al. 1977), both 
of which have been shown to inhibit the response of 
cultured sympathetic neurons to cholinergic or pep- 
tidergic factors. 
al. 1980; Potter et al. 1986; see also Lindsay et al. 
1989). In an entirely in vivo paradigm, Coulombe and 
Bronner-Fraser (1986) showed that cholinergic, 
parasympathetic neurons could store catecholamines 
when transplanted to the appropriate nvironment. 
The present experiments extend the reversibility 
phenomenon to neuropeptide expression. These find- 
ings, taken with those reviewed above (and McMahon 
and Gibson 1987), imply that the transmitter and pep- 
tide phenotypes observed in mature neurons in the 
adult organism are being actively maintained by the 
appropriate differentiation factors. This idea is consis- 
tent with the adult vertebrate nervous ystem being in a 
state of dynamic equilibrium. In this view, rather than 
being static or fixed, maturity actually represents a
balance between regression of processes and connec- 
tions, and sprouting of new processes and the forma- 
tion of novel connections (Patterson and Purves 1982; 
Purves and Lichtman 1985). It may be that this continu- 
al remodeling of the system could also involve the 
chemical identity of the neurons, an extreme form of 
synaptic plasticity. 
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Reversibility of the CDF/LIF Effects 
How permanent are the effects of CDF/L IF?  Put 
another way, if the early decision to become catechol- 
aminergic is reversible, is the subsequent decision to 
become cholinergic similarly plastic? Vidal et al. (1987) 
found that removal of skeletal muscle CM from sym- 
pathetic neurons at later times in culture resulted in a 
leveling off of the rise in choline acetyltransferase ac-
tivity and a concomitant induction of tyrosine hydroxy- 
lase activity. Reversibility in cholinergic development 
was observed by Patterson and Chun (1977), but they 
found that such changes became quantitatively less with 
neuronal age in culture. Similarly, although mature 
sympathetic neurons taken from adult rats can become 
cholinergic when exposed to the appropriate nviron- 
ment in culture, they do so at a lower frequency or with 
a slower time course (Wakshull et al. 1979; Johnson et 
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